Tudor Investment Corp’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,433
Closed -$2.44M 1549
2024
Q4
$2.44M Buy
+7,433
New +$2.44M 0.01% 685
2024
Q1
Sell
-16,070
Closed -$5.19M 1476
2023
Q4
$5.19M Buy
16,070
+9,015
+128% +$2.91M 0.04% 395
2023
Q3
$2.53M Buy
+7,055
New +$2.53M 0.03% 569
2023
Q2
Sell
-13,759
Closed -$6.59M 1553
2023
Q1
$6.59M Sell
13,759
-1,554
-10% -$744K 0.1% 239
2022
Q4
$6.44M Buy
15,313
+2,730
+22% +$1.15M 0.13% 166
2022
Q3
$5.25M Buy
12,583
+11,645
+1,241% +$4.86M 0.11% 203
2022
Q2
$464K Sell
938
-5,298
-85% -$2.62M 0.01% 1101
2022
Q1
$3.51M Sell
6,236
-113
-2% -$63.6K 0.08% 301
2021
Q4
$4.8M Buy
6,349
+5,812
+1,082% +$4.39M 0.08% 262
2021
Q3
$401K Sell
537
-6,291
-92% -$4.7M 0.01% 1211
2021
Q2
$4.4M Buy
6,828
+351
+5% +$226K 0.08% 248
2021
Q1
$3.7M Buy
6,477
+6,071
+1,495% +$3.47M 0.07% 268
2020
Q4
$237K Sell
406
-5,033
-93% -$2.94M 0.01% 1171
2020
Q3
$2.8M Buy
5,439
+2,586
+91% +$1.33M 0.12% 187
2020
Q2
$1.29M Buy
+2,853
New +$1.29M 0.06% 392
2018
Q4
Sell
-1,917
Closed -$600K 997
2018
Q3
$600K Buy
+1,917
New +$600K 0.02% 616
2018
Q1
Sell
-2,580
Closed -$616K 988
2017
Q4
$616K Buy
+2,580
New +$616K 0.02% 513
2017
Q3
Sell
-9,000
Closed -$2.04M 1080
2017
Q2
$2.04M Sell
9,000
-1,722
-16% -$390K 0.06% 183
2017
Q1
$2.14M Sell
10,722
-48,378
-82% -$9.64M 0.07% 179
2016
Q4
$10.8M Buy
59,100
+54,616
+1,218% +$9.96M 0.28% 50
2016
Q3
$735K Buy
+4,484
New +$735K 0.02% 526
2016
Q2
Sell
-3,335
Closed -$456K 1450
2016
Q1
$456K Sell
3,335
-265
-7% -$36.2K 0.01% 810
2015
Q4
$499K Buy
3,600
+156
+5% +$21.6K 0.01% 754
2015
Q3
$463K Sell
3,444
-2,487
-42% -$334K 0.02% 759
2015
Q2
$893K Sell
5,931
-1,712
-22% -$258K 0.03% 443
2015
Q1
$1.03M Sell
7,643
-50,917
-87% -$6.88M 0.03% 354
2014
Q4
$7.06M Buy
58,560
+50,546
+631% +$6.09M 0.25% 47
2014
Q3
$909K Buy
8,014
+2,064
+35% +$234K 0.03% 323
2014
Q2
$712K Buy
5,950
+300
+5% +$35.9K 0.03% 342
2014
Q1
$724K Sell
5,650
-1,795
-24% -$230K 0.03% 322
2013
Q4
$920K Buy
7,445
+2,845
+62% +$352K 0.04% 218
2013
Q3
$541K Buy
4,600
+100
+2% +$11.8K 0.02% 301
2013
Q2
$505K Buy
+4,500
New +$505K 0.04% 318